Selected sulfonylalkanoylamino hydroxyethylamine sulfonamide compounds are
effective as retroviral protease inhibitors, and in particular as inhibitors of
HIV protease. The present invention relates to such retroviral protease inhibitors
and, more particularly, relates to selected novel compounds, composition and method
for inhibiting retroviral proteases, such as human immunodeficiency virus (HIV)
protease, prophylactically preventing retroviral infection or the spread of a retrovirus,
and treatment of a retroviral infection.
